Robert Hutchens, President and CEO
San Antonio, TX
(Private)
StemBioSys is focused on enhancing the growth of adult stem cells for research, therapeutic or drug discovery applications. The company’s patented technology platforms overcome obstacles to creating clinically useful stem cell therapies. The company’s technologies represent the next evolution in cell research and are branded to the research market under the CELLvo label. The centerpiece of these enabling technologies is the company’s CELLvo Matrix. This cell-derived 3-D microenvironment allows a variety of stem cell types to replicate more rapidly, maintain a small cell size and express markers indicative of retained stem cell potency beyond that seen with traditional tissue culture substrates. The company recently announced a Xeno-free version of the company’s technology. StemBioSys also has several cell products for the research market, and all cell products are isolated and expanded on the company’s CELLvo Matrix.
[ Ссылка ]
